Monica Bertagnolli

From Wikipedia, the free encyclopedia

Monica Bertagnolli
Born1959 (age 62–63)
Education
Scientific career
Fields
Institutions
Websitewww.dana-farber.org/find-a-doctor/monica-m-bertagnolli/ Edit this at Wikidata

Monica Bertagnolli (born 1959) is an American surgical oncologist at Dana–Farber Cancer Institute and the Richard E. Wilson Professor of Surgery at Harvard Medical School.[1] She advocates for inclusion of rural communities in clinical studies and serves as Chair of the Alliance for Clinical Trials in Oncology.[2] Bertagnolli specializes in the treatment of tumors from gastrointestinal diseases.[3] She is the former President of the American Society of Clinical Oncology and was elected Fellow of the National Academy of Medicine in 2021.

Early life and education[]

Bertagnolli grew up on a cattle ranch in Wyoming.[4][5] Her parents were first generation French and Italian immigrants.[4] She earned a BE in biochemical engineering from Princeton University.[6][7] She studied medicine at the University of Utah School of Medicine and did her surgical residency at Brigham and Women's Hospital. She became board certified in 1993.[8]

Research and career[]

In 1994, Bertagnolli began as an associate surgeon at the Strang Cancer Prevention Center and attending surgeon at NewYork-Presbyterian Hospital–Cornell.[6] She joined the faculty at Harvard Medical School in 1999 and was appointed at Dana–Farber Cancer Institute in 2000.[6] Bertagnolli specializes in the treatment of tumors from gastrointestinal diseases and is an expert in treating soft-tissue sarcoma.[4] She became the Chief of Surgical Oncology at the Dana-Farber Cancer Institute in 2007, and was the first woman to hold such a position.[4] Bertagnolli's laboratory at the Dana-Farber / Harvard Cancer Center studies the role of Adenomatous polyposis coli (APC) mutations in colorectal carcinogenesis through animal studies and human clinical trials.[9]

Awards and honors[]

Her honors and awards include:

Selected publications[]

Her publications[1] include:

  • Molecular origins of cancer: Molecular basis of colorectal cancer[15]
  • Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention[16]
  • Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq[17]

Personal life[]

Bertagnolli is married with two sons.[4]

References[]

  1. ^ a b Monica Bertagnolli publications from Europe PubMed Central
  2. ^ Dutchen, Stephanie. "In the Picture". Harvard Medicine magazine. Retrieved October 24, 2021.
  3. ^ www.dana-farber.org/find-a-doctor/monica-m-bertagnolli/ Edit this at Wikidata
  4. ^ a b c d e "Hub's Humble Cancer Hero ; Surgical `Superstar' Dr. Monica Bertagnolli Tackles the Tough Cases". redorbit.com. June 24, 2007. Retrieved October 24, 2021.
  5. ^ "Women's History Month - Monica Bertagnnolli, MD". AAUW California. March 3, 2018. Retrieved October 24, 2021.
  6. ^ a b c "Monica M. Bertagnolli, MD, FACS, FASCO". ASCO. Retrieved October 24, 2021.
  7. ^ Piana, Ronald (June 3, 2018). "Monica M. Bertagnolli, MD, FASCO, a Cattle Rancher's Daughter, Becomes ASCO President". Retrieved October 24, 2021.
  8. ^ "Monica M. Bertagnolli, MD - Dana-Farber Cancer Institute | Boston, MA". dana-farber.org. Retrieved October 24, 2021.
  9. ^ "Monica M. Bertagnolli, MD". Dana-Farber / Harvard Cancer Center. Retrieved October 24, 2021.
  10. ^ "2015 Recipients of "The Charlie" – Pfizer and The Alliance for Clinical Trials in Oncology | CEO Roundtable on Cancer". ceoroundtableoncancer.org. Retrieved October 24, 2021.
  11. ^ "ASCO elects Dana-Farber/Brigham and Women's Monica Bertagnolli, MD, as 2018-19 president - Dana-Farber Cancer Institute | Boston, MA". dana-farber.org. Retrieved October 24, 2021.
  12. ^ "National Academy of Medicine Elects 100 New Members". National Academy of Medicine. October 18, 2021. Retrieved October 24, 2021.
  13. ^ "Two Dana-Farber faculty elected to National Academy of Medicine - Dana-Farber Cancer Institute | Boston, MA". dana-farber.org. Retrieved October 24, 2021.
  14. ^ "Monica Bertagnolli Bio". cancer.org. Retrieved October 24, 2021.
  15. ^ Sanford D Markowitz; Monica M Bertagnolli (December 17, 2009). "Molecular origins of cancer: Molecular basis of colorectal cancer". The New England Journal of Medicine. 361 (25): 2449–60. doi:10.1056/NEJMRA0804588. ISSN 0028-4793. PMC 2843693. PMID 20018966. Wikidata Q24617331.
  16. ^ Solomon SD; McMurray JJ; Pfeffer MA; et al. (March 17, 2005). "Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention". The New England Journal of Medicine. 352 (11): 1071–80. doi:10.1056/NEJMOA050405. ISSN 0028-4793. PMID 15713944. Wikidata Q29620087.
  17. ^ Itay Tirosh; Benjamin Izar; Sanjay M Prakadan; et al. (April 1, 2016). "Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq". Science. 352 (6282): 189–196. doi:10.1126/SCIENCE.AAD0501. ISSN 0036-8075. PMC 4944528. PMID 27124452. Wikidata Q37094024.
Retrieved from ""